Drug intelligence / Profile preview

Xifeng Huashi

Development stage
Unknown
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Xifeng Huashi is a traditional Chinese medicine (TCM) formulation primarily used for the treatment of diarrheal irritable bowel syndrome (IBS-D). It is typically administered as granules and developed according to TCM principles, particularly those outlined in the "Expert Consensus on TCM Diagnosis and Treatment of Irritable Bowel Syndrome." The formula aims to regulate intestinal flora, reduce inflammation, and improve gastrointestinal symptoms. Clinical studies have shown that it can modulate cytokine levels such as IL-8 and 5-HT, thereby improving defecation patterns in IBS-D patients. The mechanism of action involves multi-target modulation typical of herbal formulas; specific molecular targets are not fully elucidated but may include anti-inflammatory pathways[1][2][3].

Brand names
Xifeng Huashi Granules
Other names
Xi-Feng-Hua-Shi granulesXifeng Huashi Formula
02

Targets

5-HT (Serotonin receptors)

Beyond the preview

Go deeper on Xifeng Huashi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xifeng Huashi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call